Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Artiva Biotherapeutics Readies for the Next Phase of Growth with the Appointment of Neha Krishnamohan as CFO and EVP, Corporate Development and Promotion of Jennifer Bush to Chief Operating Officer
Read Article
News
2024
2023
Archive
Search news articles
February 12, 2024
Cidara Therapeutics Receives $11.14 Million Milestone Payment Following European Approval of REZZAYO
February 7, 2024
NodThera Announces Appointment of Dr. Thomas Jaecklin as Chief Medical Officer
February 7, 2024
Arvinas and Pfizer’s Vepdegestrant (ARV-471) Receives FDA Fast Track Designation for the Treatment of Patients with ER+/HER2- Metastatic Breast Cancer
February 7, 2024
Cidara Therapeutics Announces Approval of REZZAYO by the MHRA for the Treatment of Invasive Candidiasis in Adults
January 29, 2024
Michael Calore Joins 5AM Ventures as Partner, Head of Investor Relations
January 29, 2024
Skye Bioscience Announces $50.25 Million Private Placement Equity Financing
January 22, 2024
SOPHiA GENETICS Enhances RareCyte Precision Biology Services Portfolio
January 22, 2024
Dianthus Therapeutics Announces $230 Million Private Placement
January 18, 2024
Vor Bio Doses First AML Patient with VCAR33 (ALLO) and Provides Corporate Update
January 9, 2024
Skye Bioscience Receives IND Clearance for Phase 2 Clinical Trial of Nimacimab in Obesity and Chronic Kidney Disease
« Previous Page
1
2
3
4
5
…
119
Next Page »